XML 19 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 28 $ 200,600 $ (8,777,028) $ (8,576,400)
Balance, shares at Dec. 31, 2019 282,614      
Changes in Stockholders' Equity        
Conversion of redeemable convertible preferred stock to common stock upon completion of initial public offering $ 412 7,076,540   7,076,952
Conversion of redeemable convertible preferred stock to common stock upon completion of initial public offering, shares 4,117,089      
Conversion of convertible promissory notes, including embedded derivative, to common stock upon completion of initial public offering $ 12 672,512   672,524
Conversion of convertible promissory notes, including embedded derivative, to common stock upon completion of initial public offering, shares 118,470      
Issuance of common stock in initial public offering, net of offering costs $ 230 11,955,565   11,955,795
Issuance of common stock in initial public offering, net of offering costs (in shares) 2,300,000      
Exercise of stock options $ 3 4,603   4,606
Exercise of stock options, shares 27,286      
Net loss     (441,590) (441,590)
Balance at Mar. 31, 2020 $ 685 19,909,820 (9,218,618) 10,691,887
Balance, shares at Mar. 31, 2020 6,845,459      
Balance at Dec. 31, 2020 $ 689 21,779,340 (14,239,075) 7,540,954
Balance, shares at Dec. 31, 2020 6,891,608      
Changes in Stockholders' Equity        
Exercise of stock options $ 1 3,016   3,017
Exercise of stock options, shares 3,868      
Exercise of warrants $ 5 (5)    
Exercise of warrants, shares 51,644      
Share based compensation expense   23,977   23,977
Net loss     (3,199,673) (3,199,673)
Balance at Mar. 31, 2021 $ 695 $ 21,806,328 $ (17,438,748) $ 4,368,275
Balance, shares at Mar. 31, 2021 6,947,120